Study of LBH589, A Deacetylase Inhibitor in Patients With Recurrent or Refractory Hodgkin or Non-Hodgkin's Lymphoma

NCT01032148 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped lack of funding

Conditions

Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma

Interventions

DRUG: LBH589

Sponsor

Roswell Park Cancer Institute

Collaborators

[object Object]